RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi, E Thompson… - Scientific reports, 2020 - nature.com
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study
SC Mendelsohn, A Fiore-Gartland… - The Lancet Global …, 2021 - thelancet.com
Background A rapid, blood-based triage test that allows targeted investigation for
tuberculosis at the point of care could shorten the time to tuberculosis treatment and reduce …
tuberculosis at the point of care could shorten the time to tuberculosis treatment and reduce …
Detection of tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-infected persons on antiretroviral therapy
HIV-infected individuals are at high risk of tuberculosis disease and those with prior
tuberculosis episodes are at even higher risk of disease recurrence. A non-sputum …
tuberculosis episodes are at even higher risk of disease recurrence. A non-sputum …
Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study
CT Turner, RK Gupta, E Tsaliki, JK Roe… - The Lancet …, 2020 - thelancet.com
Background Blood transcriptional signatures are candidates for non-sputum triage or
confirmatory tests of tuberculosis. Prospective head-to-head comparisons of their diagnostic …
confirmatory tests of tuberculosis. Prospective head-to-head comparisons of their diagnostic …
Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis
H Mulenga, CZ Zauchenberger, EW Bunyasi… - PLoS …, 2020 - journals.plos.org
Introduction Host blood transcriptomic biomarkers have potential as rapid point-of-care
triage, diagnostic, and predictive tests for Tuberculosis disease. We aimed to summarise the …
triage, diagnostic, and predictive tests for Tuberculosis disease. We aimed to summarise the …
[HTML][HTML] Host blood RNA signatures predict the outcome of tuberculosis treatment
EG Thompson, Y Du, ST Malherbe, S Shankar, J Braun… - Tuberculosis, 2017 - Elsevier
Biomarkers for tuberculosis treatment outcome will assist in guiding individualized treatment
and evaluation of new therapies. To identify candidate biomarkers, RNA sequencing of …
and evaluation of new therapies. To identify candidate biomarkers, RNA sequencing of …
Concise gene signature for point‐of‐care classification of tuberculosis
J Maertzdorf, G McEwen, J Weiner 3rd… - EMBO molecular …, 2016 - embopress.org
There is an urgent need for new tools to combat the ongoing tuberculosis (TB) pandemic.
Gene expression profiles based on blood signatures have proved useful in identifying genes …
Gene expression profiles based on blood signatures have proved useful in identifying genes …
Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis
RK Gupta, CT Turner, C Venturini, H Esmail… - The Lancet …, 2020 - thelancet.com
Background Multiple blood transcriptional signatures have been proposed for identification
of active and incipient tuberculosis. We aimed to compare the performance of systematically …
of active and incipient tuberculosis. We aimed to compare the performance of systematically …
Diagnostic biomarkers for active tuberculosis: progress and challenges
BMF Nogueira, S Krishnan… - EMBO Molecular …, 2022 - embopress.org
Tuberculosis (TB) is a leading cause of morbidity and mortality from a single infectious
agent, despite being preventable and curable. Early and accurate diagnosis of active TB is …
agent, despite being preventable and curable. Early and accurate diagnosis of active TB is …
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study
A Penn-Nicholson, T Hraha, EG Thompson… - PLoS …, 2019 - journals.plos.org
Background A nonsputum blood test capable of predicting progression of healthy individuals
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …
相关搜索
- transcriptomic signature disease risk
- transcriptomic signature treatment response
- treatment response disease risk
- gene signatures tuberculosis diagnosis
- gene signatures host response
- host response tuberculosis diagnosis
- treatment response tuberculosis recurrence
- gene signatures systematic comparison
- treatment response antiretroviral therapy
- gene signature classification of tuberculosis